GovChime
Notice ID: 68618a955ba7400d9722dad2f236a9f3SolicitationArchived

Various Radiopharmaceuticals

Archived on September 27, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
4:00 PM CDT
Posted
September 11, 2025
Notice type
Solicitation
Set-aside
No Set aside used
Agency
Department of WarDepartment of the Army

Notice details

Office
W40M MRC0 WEST
Place of performance
JBSA Ft Sam Houston, 78234
Last updated
Nov 8, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
W81K0025QA125
Notice ID
68618a955ba7400d9722dad2f236a9f3

Description

***AMENDMENT 0003*** THE PURPOSE OF THIS AMENDMENT IS TO REMOVE DFARS CLAUSE 252.204-7012 FROM THE SOLICITATION. THE QUOTE DUE DATE IS HEREBY EXTENDED TO 12 SEP 2025 AT 1600 CST. ***AMENDMENT 0002*** THE PURPOSE OF THIS AMENDMENT IS TO REVISE THE REQUIREMENT FROM A FIVE-YEAR ORDERING PERIOD TO A ONE-YEAR ORDERING PERIOD. THE QUOTE DUE DATE IS HEREBY EXTENDED TO 11 SEP 2025 AT 1600 CST. ***AMENDMENT 0001*** THE PURPOSE OF THIS AMENDMENT IS TO: (1) INCORPORATE CLIN 0011 "POST AWARD CONFERENCE" WHICH WILL SATISFY THE $100.00 MINIMUM GUARANTEE ESTABLISHED FOR THE RESULTANT IDIQ CONTRACT AND (2) UPDATE THE STATEMENT OF WORK TO SPECIFY THE DELIVERY TIMEFRAME FOR IOFLUPANE. Solicitation W81K00-25-Q-A125 is hereby issued for various radiopharmaceuticals in support of Brooke Army Medical Center (BAMC), JBSA Fort Sam Houston, TX. The resultant contract will be a Firm-Fixed-Price (FFP) Indefinite Delivery Indefinite Quantity (IDIQ) contract with a five-year ordering period. Period of Performance: 01 OCT 2025 through 30 SEP 2030. Refer to attached Solicitation W81K00-25-Q-A125 and Statement of Work. Solicitation PSC/NAICS 6505 (Drugs and Pharmaceutical Products) / 325412 (Phrmaceutical Preparation Manufacturing)

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (10)

  • Solicitation Amendment W81K0025QA1250003 SF 30.pdf

    146 KBAdded in Solicitation version 8Posted
    Download
  • Solicitation Amendment - W81K0025QA1250003.pdf

    3.0 MBAdded in Solicitation version 8Posted
    Download
  • Solicitation Amendment W81K0025QA1250002 SF 30.pdf

    3.3 MBAdded in Solicitation version 6Posted
    Download
  • Solicitation Amendment - W81K0025QA1250002.pdf

    2.7 MBAdded in Solicitation version 6Posted
    Download
  • Solicitation Amendment W81K0025QA1250001 SF 30.pdf

    3.2 MBAdded in Solicitation version 3Posted
    Download
  • Solicitation Amendment - W81K0025QA1250001.pdf

    2.7 MBAdded in Solicitation version 3Posted
    Download
  • Statement Of Work (W81K0025QA125)_rev1.pdf

    143 KBAdded in Solicitation version 3Posted
    Download
  • Solicitation - W81K0025QA125.pdf

    2.7 MBAdded in Solicitation version 2Posted
    Download
  • Statement Of Work.pdf

    133 KBAdded in Solicitation version 2Posted
    Download
  • List of Required Radiopharmaceuticals.pdf

    109 KBAdded in Presolicitation version 6Posted
    Download

Lifecycle

  1. 4
    Version 4PresolicitationArchived

    Various Radiopharmaceuticals

    Notice cff017a0667148678788a9e7f3280403 on SAM.gov

  2. 2
    Version 2SolicitationArchived

    Type changed from Presolicitation to Solicitation

    Various Radiopharmaceuticals

    Notice 8efa90cfcf7c443690d625b8ff51ee58 on SAM.gov

  3. 3
    Version 3SolicitationArchived

    Various Radiopharmaceuticals

    Notice 96fd30f186014c08ab619104094edef1 on SAM.gov

  4. 6
    Version 6SolicitationArchived

    Various Radiopharmaceuticals

    Notice fa8405eb0689437ea1d37f02084c78c8 on SAM.gov

  5. 8
    Version 8SolicitationArchivedCurrent

    Various Radiopharmaceuticals

    Notice 68618a955ba7400d9722dad2f236a9f3 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81K0025QA125

Archive Date

Sep 27, 2025